Literature DB >> 14650572

The silent killer: psychological issues in ovarian cancer.

Ruth McCorkle1, Jeannie Pasacreta, Siew Tzuh Tang.   

Abstract

Ovarian cancer represents about 4% of all cancers in women and is the fifth leading cause of death in the United States each year. Ovarian cancer is associated with uncertainty, anxiety, and depression. Many women present with advanced disease at diagnosis and are faced with aggressive surgical and medical protocols to treat them. To meet the needs of women with ovarian cancer, the effects of their physical problems on psychological adjustment must be identified. Health care professionals must closely monitor women with ovarian cancer to identify those who may require ongoing psychological care or psychiatric intervention. This article presents an overview of ovarian cancer, focusing on the psychological effects, and an intervention by oncology nurse specialists to address both the physical and emotional distress that accompanies ovarian cancer. The importance of screening for psychological distress is emphasized.

Entities:  

Mesh:

Year:  2003        PMID: 14650572     DOI: 10.1097/00004650-200311000-00005

Source DB:  PubMed          Journal:  Holist Nurs Pract        ISSN: 0887-9311            Impact factor:   1.000


  13 in total

Review 1.  A systematic review of ovarian cancer and fear of recurrence.

Authors:  Melissa Ozga; Carol Aghajanian; Shannon Myers-Virtue; Glynnis McDonnell; Sabrina Jhanwar; Shira Hichenberg; Isabel Sulimanoff
Journal:  Palliat Support Care       Date:  2015-03-02

2.  The utilization of oncology web-based resources in Spanish-speaking Internet users.

Authors:  Charles B Simone; Margaret K Hampshire; Carolyn Vachani; James M Metz
Journal:  Am J Clin Oncol       Date:  2012-12       Impact factor: 2.339

3.  Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.

Authors:  Canan Schumann; Stephanie Chan; Oleh Khalimonchuk; Shannon Khal; Vitaliya Moskal; Vidhi Shah; Adam W G Alani; Olena Taratula; Oleh Taratula
Journal:  Mol Pharm       Date:  2016-05-26       Impact factor: 4.939

4.  Quality of life among women after surgery for ovarian cancer.

Authors:  Dena Schulman-Green; Elizabeth Ercolano; Michael Dowd; Peter Schwartz; Ruth McCorkle
Journal:  Palliat Support Care       Date:  2008-09

5.  Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.

Authors:  Katrin M Sjoquist; Michael L Friedlander; Rachel L O'Connell; Merryn Voysey; Madeleine T King; Martin R Stockler; Amit M Oza; Kim Gillies; Julie K Martyn; Phyllis N Butow
Journal:  Oncologist       Date:  2013-10-09

Review 6.  Issues of ovarian cancer survivors in the USA: a literature review.

Authors:  Katrina F Trivers; Jennifer Rees Patterson; Katherine B Roland; Juan L Rodriguez
Journal:  Support Care Cancer       Date:  2013-07-12       Impact factor: 3.603

7.  Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patients.

Authors:  Lauren Garvin; George M Slavich; Andrew Schrepf; Lauren Z Davis; Premal H Thaker; Michael J Goodheart; Steve W Cole; Anil K Sood; Susan K Lutgendorf
Journal:  Psychooncology       Date:  2021-04-01       Impact factor: 3.894

8.  Psychological Distress during Ovarian Cancer Treatment: Improving Quality by Examining Patient Problems and Advanced Practice Nursing Interventions.

Authors:  Cynthia Kline O'Sullivan; Kathryn H Bowles; Sangchoon Jeon; Elizabeth Ercolano; Ruth McCorkle
Journal:  Nurs Res Pract       Date:  2011-08-01

9.  Cancer patients' self-reported attitudes about the Internet.

Authors:  Sheryl P LaCoursiere; M Tish Knobf; Ruth McCorkle
Journal:  J Med Internet Res       Date:  2005-07-01       Impact factor: 5.428

Review 10.  Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates.

Authors:  Sam Watts; Philip Prescott; Jessica Mason; Natalie McLeod; George Lewith
Journal:  BMJ Open       Date:  2015-11-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.